Article
Cell-free DNA for the detection of fetal aneuploidy.
Fertility and sterility - 1 Feb 2018
Goldwaser Tamar, Klugman Susan
Abstract excerpt
Screening for fetal aneuploidy via cell-free DNA was described more than two decades ago and has been used clinically by obstetric providers in the United States for more than 5 years. Cell-free DNA affords excellent detection of fetal Down syndrome and other common aneuploidies and thus is sought by patients and providers. However, owing to the source of the DNA and the nature of the screening test, scenarios...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
